Wales and the artificial pancreas: how far the adult rollout has come
Around a quarter of adults with Type 1 diabetes in Wales are now using hybrid closed loop systems, though rollout has happened without ring-fenced funding.
If you have Type 1 in Wales, an artificial pancreas is no longer a rare thing reserved for a lucky few. By mid 2026, around a quarter of adults with Type 1 in Wales were using a hybrid closed loop system, and uptake is still climbing. It is real, ordinary NHS care now, not a trial. What it is not yet is universal, and the people running it have been open that keeping the momentum going needs more investment.
- A hybrid closed loop is an insulin pump and a glucose sensor that talk to each other, with the pump nudging your background insulin up and down automatically based on your readings.
- It is called hybrid because it is not hands-off: you still count carbs and tell it about meals, and it still needs your input.
- Around a quarter of adults with Type 1 in Wales are now using one, a big jump driven by simpler education and onboarding.
- The rollout has happened without ring-fenced funding, and clinicians have warned that reaching everyone eligible needs more investment.
- If you have assumed you are not eligible, that assumption is worth re-checking with your team.
A quarter of adults, and still rising
The headline figure comes from a Diabetes Week 2026 update on how Wales has approached closed loop technology. Around a quarter of adults with Type 1 there are now using a hybrid closed loop system. That is a striking number for a technology that, only a few years ago, most people with Type 1 could not get at all outside a research study.
What made the difference in Wales was less a single funding announcement and more a change in how teams get people started: simpler education courses, smoother onboarding, and a pathway that treats closed loop as a standard option rather than a special request. The result is more people set up and running in less time.
Real progress, with a real pressure behind it
The genuinely good news is that this is happening as normal NHS care, and the direction of travel is toward more access, not less. The catch, and the clinicians involved have said it plainly, is that the growth has come without money set aside specifically for it. Momentum built on goodwill and efficiency can stall if the resource behind it does not keep pace, and reaching the people who are still eligible but not yet set up is the harder, slower part.
For you, that means two things. If you have Type 1 in Wales, a closed loop is a real, current option worth asking about by name, not a distant promise. And if a waiting list or a stretched service is the reason you are told to wait, that is a capacity issue rather than a sign you personally do not qualify. Knowing which one you are dealing with is worth clarifying.